Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.
about
Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infectionProgress in Fourier transform infrared spectroscopic imaging applied to venereal cancer diagnosisMolecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen.Validation of human papillomavirus genotyping by signature DNA sequence analysis.Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistenceComparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer.HPV genotype detection using hybrid capture sample preparation combined with whole genome amplification and multiplex detection with Luminex XMAPGlobal proficiency study of human papillomavirus genotyping.Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyPrevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.Human papillomavirus is not associated with colorectal cancer in a large international studyComparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis.Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detectionComparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay.Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica.Evaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulationDistribution of Human Papillomavirus Genotypes in Liquid-based Samples; Abundance of HPV-53 in Tehran, Iran.Performance of commercial reverse line blot assays for human papillomavirus genotyping.The 2010 global proficiency study of human papillomavirus genotyping in vaccinology.Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits.Human Papillomavirus (HPV) Genotyping: Automation and Application in Routine Laboratory Testing.Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-upHPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST.Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus.Validation of the SPF10 LiPA human papillomavirus typing assay using formalin-fixed paraffin-embedded cervical biopsy samples.Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology.Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women.Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in AfricaGlobal improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency StudyCommercially available assays for multiplex detection of alpha human papillomaviruses.Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study.Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.A rapid DNA extraction method suitable for human papillomavirus detection.Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.Cervical Infection With Vaccine-Associated Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.Trends in human papillomavirus-related oropharyngeal cancer in Israel.No evidence for human papillomavirus infection in focal cortical dysplasia IIb.
P2860
Q24568227-5F9D7E07-5553-412F-870F-39388C27696FQ27025100-D040756F-B2A9-4D13-BF4C-CDABFFDB4F3BQ33428795-1A333F44-AEAC-4554-A1B6-43CAE0B52AE6Q33450984-A6616FAF-C6CB-4FE4-8233-85D4BFB2CD99Q34064401-08EBE992-F5D1-4D46-8BDE-1A0130467E17Q34176414-2F608E9C-EBCC-4EB7-9E2B-7DF0D65AA076Q34198635-3AED1476-2D83-41A9-B3F7-17972379554CQ34239718-F0CD3F51-D2A0-42C5-AD72-F2ECA7CFD958Q34489632-9C2D6172-6621-47F3-8B30-97C169926759Q34520216-6348B3F0-F231-4C20-83A2-C1BE61DA7473Q34622565-6487E828-7AA6-412C-94D1-D162536733C8Q34723700-B1FEC6E8-D31B-4420-9D88-E967BCBF8966Q34913072-54B809E3-EDBD-46C8-869C-07B0B58ECAFCQ35066537-EDC73240-9853-4765-9C7E-98115E5CFDEDQ35066675-49C90A42-2864-496F-8E31-72E22BA179BEQ35093306-87532BB2-A7C8-4063-AA61-B730D08F137BQ35185477-F4C23468-5E06-418E-ABED-AF196A9675B7Q35545161-3BA5395F-C1DF-414F-A290-541D1F170FB7Q35942878-9CE86FD7-F0CD-409C-8D49-8A56ACEEF074Q36118729-EBD40175-79AA-4A5C-BA33-7CBC6E6B6C3DQ36383927-FCC9E55A-A285-4EDF-80EA-F52A69326641Q36466049-F6242C60-EB7A-4765-916E-3BC1F3D5B53FQ36557818-736539B5-870B-4EB9-88F4-BD5C6E7D7D0EQ36645480-963B53EB-3103-474A-97D0-65D46C35813FQ37078556-91E25585-E04B-4D8B-A0C2-4EFCA25B32C7Q37116753-08A43322-16F2-49A3-875C-363E231F03C4Q37256252-1A2493CE-22EF-4F6C-B8A1-ACC4B874D8F8Q37271640-CE5EADE8-0484-41BE-91D9-7CD9FC9D0599Q37438579-7217A968-4954-4C04-87A1-29C323E6FE77Q37461655-D92F735C-7445-48B2-8F6A-5BE667A6E88AQ37519825-241753F8-C078-425E-84E0-4B92D58C41FDQ37546177-AA78C6EC-9BFD-4F49-AD41-C2906A87DB3BQ37800921-37D76A6C-6613-4F0A-8E8B-D9B58680C275Q37844517-1F3E0EA6-0588-4CFF-AF15-CBDFEE701E93Q38023288-10146A0D-DA72-4306-8EE2-020B0F3161DDQ39032885-2352915E-142E-4279-B9C2-83F6BF757FC2Q39629659-1B7218AF-F959-40BA-97DD-80523D982BFEQ40647908-02E65816-7A80-408F-A1A7-98F943E68443Q41578639-F7DEA7A0-681A-4202-A073-52B097ABBD70Q41612629-9A14EC08-B952-41FC-BDEE-44ADFF2C4A22
P2860
Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Comparison of the performance ...... r detecting genital HPV types.
@en
Comparison of the performance ...... r detecting genital HPV types.
@nl
type
label
Comparison of the performance ...... r detecting genital HPV types.
@en
Comparison of the performance ...... r detecting genital HPV types.
@nl
prefLabel
Comparison of the performance ...... r detecting genital HPV types.
@en
Comparison of the performance ...... r detecting genital HPV types.
@nl
P2093
P2860
P356
P1476
Comparison of the performance ...... or detecting genital HPV types
@en
P2093
Anco Molijn
Angelika Iftner
Barbara Holz
Betti Schopp
Christian Munk
Karl-Ulrich Petry
Peter J F Snijders
Susanne Krüger Kjaer
Thomas Iftner
P2860
P304
P356
10.1002/JMV.21191
P577
2008-07-01T00:00:00Z